People: Quintiles Transnational Holdings Inc (Q.N)

Q.N on New York Stock Exchange

60.39USD
19 Dec 2014
Price Change (% chg)

$1.01 (+1.70%)
Prev Close
$59.38
Open
$60.00
Day's High
$60.47
Day's Low
$59.59
Volume
572,522
Avg. Vol
190,043
52-wk High
$60.71
52-wk Low
$43.82

Search Stocks

Gillings, Dennis 

Brief Biography

Dr. Dennis B. Gillings, CBE, Ph.D., is Executive Chairman of the Board of Quintiles Transnational Holdings Inc. He also served as Chief Executive Officer from 1982 to December 2012. Dr. Gillings serves on several other boards and councils. He formerly served as the founding Chairman of the Association of Clinical Research Organizations, a Washington-based trade group formed in 2002. He also formerly served as a director of Icagen, Inc., a biopharmaceutical company, from 1997 until June 2011. Dr. Gillings received a diploma in Mathematical Statistics from Cambridge University in 1967 and a Ph.D. in Mathematics from the University of Exeter, England, in 1972. He served for more than 15 years as a professor at the University of North Carolina at Chapel Hill and received the Honorary Degree of Doctor of Science from the University in May 2001. He was awarded the Commander in The Most Excellent Order of the British Empire in 2004. In 2006, Dr. Gillings was appointed Pro Chancellor of the University of Southampton and serves as a Trustee on the Southampton University Development Trust.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
871,212 -- 1,063,280 1,934,490

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Dennis Gillings

1,934,490

Thomas Pike

2,585,810

Kevin Gordon

4,153,570

James Erlinger

--

Derek Winstanly

2,954,360

Fred Cohen

--
As Of 30 Dec 2013
Search Stocks